EFFICACY OF FDA-APPROVED DISEASE-MODIFYING THERAPIES (DMTS) VERSUS ACTIVE COMPARATOR MEDICATIONS FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS: A SYSTEMATIC REVIEW

被引：0
|
作者：
Lingohr-Smith, M. [1 ]
Deitelzweig, C. [2 ]
Lin, G. [3 ]
Lin, J. [4 ]
机构：
[1] Novosys Hlth, Basking Ridge, NJ USA
[2] Novosys Hlth, Green Brook, NJ USA
[3] Novosys Hlth, Morris Plains, NJ USA
[4] Novosys Hlth, Martinsville, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO106
引用
收藏
页码：S324 / S324
页数：1
相关论文
共 50 条
  • [21] Disease-modifying therapy in adult relapsing-remitting multiple sclerosis
    Rosenzweig, Tamara M.
    Hartman, Sarah
    MacKenzie, Elizabeth
    FORMULARY, 2010, 45 (08) : 252 - 262
  • [22] Comparative safety of high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis
    Sladowska, Katarzyna
    Kawalec, Pawel
    Holko, Przemyslaw
    Osiecka, Oktawia
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5479 - 5500
  • [23] Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis
    Merkel, B.
    Jokubaitis, V.
    Spelman, T.
    Horakova, D.
    Havrdova, E.
    Trojano, M.
    Izquierdo, G.
    Lugaresi, A.
    Prat, A.
    Girard, M.
    Duquette, P.
    Sola, P.
    Ferraro, D.
    Grammond, P.
    Hupperts, R.
    Bergamaschi, R.
    Alroughani, R.
    Boz, C.
    Terzi, M.
    Pucci, E.
    Van Pesch, V.
    Grand'Maison, F.
    Fernandez-Bolanos, R.
    Lechner-Scott, J.
    Spitaleri, D.
    Shaygannejad, V.
    Iuliano, G.
    Granella, F.
    Solaro, C.
    Prevost, J.
    Petersen, T.
    Olascoaga, J.
    Ramo-Tello, C.
    Verheul, F.
    McCombe, P.
    Slee, M.
    Sanchez-Menoyo, J. L.
    Cristiano, E.
    Ozakbas, S.
    Saladino, M. L.
    Ampapa, R.
    Vucic, S.
    Moore, F.
    Deri, N.
    Alkhaboori, J.
    Barnett, M.
    Van der Walt, A.
    Butzkueven, H.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 71 - 73
  • [24] TIMING OF HIGH-EFFICACY DISEASE MODIFYING THERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Merkel, Bernd
    Jokubaitis, Vilija
    Spelman, Tim
    Lechner-Scott, Jeannette
    McCombe, Pamela
    Slee, Mark
    Vucic, Steve
    Skibina, Olga
    Barnett, Michael
    Hodgkinson, Suzanne
    Butzkueven, Helmut
    Kalincik, Tomas
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05):
  • [25] Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis
    Liu, Zhuoyi
    Liao, Qiao
    Wen, Haicheng
    Zhang, Yihao
    AUTOIMMUNITY REVIEWS, 2021, 20 (06)
  • [26] Sequencing of disease-modifying therapies for relapsing-remitting multiple sclerosis: a theoretical approach to optimizing treatment
    Grand'Maison, Francois
    Yeung, Michael
    Morrow, Sarah A.
    Lee, Liesly
    Emond, Francois
    Ward, Brian J.
    Laneuville, Pierre
    Schecter, Robyn
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (08) : 1419 - 1430
  • [27] Predictors of Response to First-Line Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis
    Castillo-Trivino, Tamara
    Gajofatto, Alberto
    Bacchetti, Peter
    Waubant, Emmanuelle
    NEUROLOGY, 2010, 74 (09) : A155 - A155
  • [28] Injectable Disease-Modifying Therapy for Relapsing-Remitting Multiple Sclerosis: A Review of Adherence Data
    Caon, Christina
    Saunders, Carol
    Smrtka, Jennifer
    Baxter, Nancy
    Shoemaker, Jennifer
    JOURNAL OF NEUROSCIENCE NURSING, 2010, 42 (05) : S5 - S9
  • [29] Discontinuation of Disease-Modifying Therapy for Patient with Relapsing-Remitting Multiple Sclerosis
    Yano, Hajime
    Gonzalez, Cindy T.
    Healy, Brian C.
    Glanz, Bonnie I.
    Weiner, Howard L.
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 47 - 47
  • [30] Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis
    Fogarty, Emer
    Schmitz, Susanne
    Tubridy, Niall
    Walsh, Cathal
    Barry, Michael
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 23 - 30
12345